Brief: Galderma To Present Post-Marketing Data From ARTIST Study On Its Restylane Hyaluronic Acid Injectables Portfolio
24/09/2025 06:03
Sept 24 (Reuters) - GALDERMA GROUP AG GALD.S: GALDERMA WILL PRESENT POST-MARKETING DATA FROM ARTIST STUDY ON ITS RESTYLANE HYALURONIC ACID (HA) INJECTABLES PORTFOLIO Source text: ID:nBwb10hySa Further company coverage: GALD.S (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Galderma AG
See all newsBrief: Galderma Receives U.S. FDA Approval For Differin Epiduo Acne Gel Prescription-To-Otc Switch
Bayer down after 'mixed reception' at U.S Supreme Court
Europe Research Roundup: Asta Energy Solutions, Dassault Systemes, Nokia
Swiss stocks - Factors to watch on April 24
Skincare company Galderma posts 25.5% sales leap, driven by US market (updated)